| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BILINSKY IGOR | Chief Operating Officer | C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS | /s/ Igor Bilinsky | 06 Mar 2026 | 0001594604 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Common Stock | Options Exercise | +31,246 | +28% | $0.000000* | 142,394 | 05 Mar 2026 | Direct | F1 | |
| transaction | IOVA | Common Stock | Tax liability | -16,628 | -12% | $4.58* | 125,766 | 05 Mar 2026 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Restricted Stock Units | Options Exercise | -31,246 | -33% | $0.000000* | 62,504 | 05 Mar 2026 | Common stock | 31,246 | Direct | F4, F5, F6 |
| Id | Content |
|---|---|
| F1 | Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
| F2 | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. |
| F3 | Represents common stock remaining after deducting the common stock withheld for taxes. |
| F4 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| F5 | The remaining RSUs will vest in equal quarterly installments. |
| F6 | Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |